Research Article
Sarcopenic Obesity and Cognitive Functioning: The Mediating Roles of Insulin Resistance and Inflammation?
Table 2
Insulin resistance, CRP, and cognitive functioning comparisons by body composition and age group.
| Measure | Sarcopenic obese | Nonsarcopenic obese | Sarcopenic nonobese | Reference group |
| Aged 60–69 | | | | | IRHOMA, median | 2.72 | 3.68 | 1.92 | 1.89 | CRP (mg/L), median | 6.40 | 3.40 | 1.90 | 1.40 | Cognitive functioning, mean (SD) | 49.59 (23.1) | 53.61 (18.2) | 50.37 (20.3) | 54.80 (18.4) | Aged 70+ | | | | | IRHOMA, median | 2.86 | 3.19 | 1.89 | 1.70 | CRP (mg/L), median | 4.20 | 3.00 | 2.60 | 2.30 | Cognitive functioning, mean (SD) | 32.92 (15.8) | 43.66 (17.7) | 38.26 (15.2) | 45.88 (15.4) |
|
|